Why is Valiant Laborato falling/rising?

As of 31-Jul, Valiant Laboratories Ltd is experiencing a decline in its stock price, currently at 92.00, which represents a decrease of 0.45 or 0.49%. The stock has underperformed significantly over various periods, with a 1-week return of -5.88% and a 1-month return of -17.60%. Despite a recent outperformance against its sector by 1%, the stock is trading below all key moving averages, indicating a bearish trend. The company's recent financial results show positive net sales and profit after tax, but these are overshadowed by long-term weaknesses, including a negative return on equity and a significant decline in net sales and operating profit over the past five years.
In the broader market context, Valiant Laboratories has underperformed the Sensex, which has only declined by 1.22% over the past week, while the stock has dropped more than five times that amount. The company's weak long-term fundamentals, highlighted by a negative EBITDA and poor debt servicing ability, contribute to its risk profile, making it less attractive to investors. Overall, while there are some positive indicators in the short term, the long-term outlook remains bleak, leading to the stock's current downward movement.